Skip to main content
Signal8
Vargeese Chandra profile photo

Chandra Vargeese

CIK: 0001657675

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (20.0%)

Position reduction

Option Exercises (M)2 (40.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Wave Life Sciences Ltd. logo
WVE

Wave Life Sciences Ltd.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Feb 9, 2026
    Sale(S)
    Direct
    3.2K shares at avg. $13.45$43K
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Feb 5, 2026
    Award(A)
    Direct
    45.6K shares-
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Mar 4, 2025
    Exercise(M)
    Direct
    91.8K shares at avg. $2.48$228K
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Feb 4, 2025
    Award(A)
    Direct
    37K shares-
  • Wave Life Sciences Ltd. logo
    WVE

    Wave Life Sciences Ltd.

    Jan 23, 2025
    Exercise(M)
    Direct
    46K shares at avg. $2.48$114K

1-5 of 5

About Vargeese Chandra

Vargeese Chandra (SEC CIK 0001657675) files insider reports with the SEC as Officer of Wave Life Sciences Ltd. (WVE).

Signal8 holds 4 ownership filings by Vargeese Chandra, all Form 4s, filed between Jan 24, 2025 and Feb 11, 2026. Those filings report 5 transactions, from Jan 23, 2025 to Feb 9, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vargeese Chandra's filings is in CAMBRIDGE, MA.

Recent filings by Vargeese Chandra

  • Feb 9, 2026: Open-market sale of WVE shares (Form 4, code S).
  • Feb 5, 2026: Grant or award of WVE shares (Form 4, code A).
  • Mar 4, 2025: Option exercise of WVE shares (Form 4, code M).
  • Feb 4, 2025: Grant or award of WVE shares (Form 4, code A).
  • Jan 23, 2025: Option exercise of WVE shares (Form 4, code M).

Other insiders filing for Wave Life Sciences Ltd. (WVE)

How to read Form 4 transaction codes